EX-10.1 4 w33874exv10w1.htm EXHIBIT 10.1 exv10w1
 

     
(LIFESCAN LOGO)
  LifeScan, Inc. 1000 Gibraltar Drive, Milpitas, CA 95035-6312
Tel: 408-263-9789 Fax: 408.946.6070 www.LifeScan.com
December 7, 2005
Andrew Denver
Chairman
Universal Biosensors Inc
27, Woodviile Ave
Wahroonga NSW 2076
Australia
Dear Andrew,
I am writing to you today to propose amending our current License Agreement.
This amendment will be effective as of the date of this letter and amends the License Agreement (“Agreement”) entered into the 1st day of April, 2002 by and between Universal Biosensors, Inc., a Delaware corporation having a principal place of business at 2711 Centerville Road, Suite 400, Wilmington, Delaware 19808 (“Universal Biosensors”) and LifeScan Inc., a California corporation having its principal place of business at 1000 Gibraltar Drive, Milpitas, California 95035 (“LifeScan”). LifeScan and Universal Biosensors are sometimes collectively referred to herein individually as a “Party” or collectively as the “Parties.”
In consideration for the covenants and undertakings set forth herein and in the Agreement, the Parties hereby agree;
Section 1.6 is hereby deleted in its entirety and replaced by the following Section:
     1.6 “LIFESCAN’s Field” means diabetes, including, without limitation:
  (a)   measurement of analytes for purposes of diagnosing, managing, monitoring, prognosticating, treating, or curing diabetes; and
 
  (b)   the measurement of glucose in humans for any other purpose, including, without limitation, tight glycemic control

Page 1 of 2

 

The Parties agree that all other provisions in the Agreement remain.
In witness whereof, LifeScan and Universal Biosensors have caused these present to be signed.
AGREED AND ACCEPTED TO:
                 
UNIVERSAL BIOSENSORS INC       LIFESCAN, INC.
 
                
By:
  /s/ Andrew Denver       By:   /s/ Eric P. Milledge
 
               
Name: Andrew Denver       Name: Eric P. Milledge
Title: Chairman       Title: Company Group Chairman
Date: Jan 9 2006       Date: 01/04/06

Page 2 of 2

 

Exhibit 10.1
LICENSE AGREEMENT
     THIS AGREEMENT, is by and between LifeScan, Inc., a California corporation having its principal place of business at 1000 Gibraltar Drive, Milpitas, California 95035 (“LIFESCAN”), and Universal Biosensors Inc., a Delaware corporation having its principal place of business at 2711 Centerville Road, Suite 400, Wilmington, Delaware 19808 (“UNIVERSAL BIOSENSORS”).
     WHEREAS, LIFESCAN has acquired from USF Filtration and Separations Group Inc. (“FSG”) all right, title, and interest in and to certain know-how, patents and patent applications relating to electrochemical sensors;
     WHEREAS, UNIVERSAL BIOSENSORS desires to obtain a license in and to this know-how and these patents and patent applications and LIFESCAN desires to grant the license to UNIVERSAL BIOSENSORS.
     NOW, THEREFORE, in consideration of the premises and mutual covenants herein contained, the parties agree to the following:
1.   DEFINITIONS.
  1.1   “Affiliate” means any entity that directly or indirectly controls, is controlled by, or is under common control with a party to the Agreement. “Control” shall mean the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of the entity, whether through the ownership of voting securities, by contract or otherwise.
 
  1.2   “Effective Date” means April 1, 2002.
 
  1.3   “Field” means a field-of-use.
 
  1.4   “Licensed Fields” means all Fields outside of LIFESCAN’s Field.
 
  1.5   “LIFESCAN Acquired Know-How” means all know-how, data, and information acquired from FSG by LIFESCAN and related to the LIFESCAN Patents.
 
  1.6   “LIFESCAN’s Field” means:
     a.) measurement of analytes for purposes of diagnosing, managing, monitoring, prognosticating, treating, or curing diabetes:
     b.) measurement of blood coagulation; and

 

 

     c.) measurement for purposes of diagnosing, managing, monitoring, prognosticating, treating, or curing blood coagulopathies excluding the measurement of total hemoglobin.
  1.7   “LIFESCAN Acquired Patents” means those applications and patents acquired by LIFESCAN from FSG and identified on Exhibit A attached hereto and made a part hereof, as well as any patents issuing therefrom, foreign counterparts, divisions, continuations, renewals, reissues, re-examinations, patent extensions, and substitutions thereof.
 
  1.8   “Product” means an article within the Licensed Fields that either falls within the scope of a Valid Claim of one of the LIFESCAN Acquired Patents or embodies LIFESCAN Acquired Know-How.
 
  1.9   “Term” means the period beginning on the Effective Date and ending at the end of the term of the last to expire of the LIFESCAN Acquired Patents unless terminated earlier pursuant to Section 5.
 
  1.10   “Valid Claim“ means a claim of an issued, unexpired patent that has not been held invalid by a court of competent jurisdiction or held unpatentable in a re-examination procedure in the United States Patent and Trademark Office.
2.   LICENSE.
  2.1   a.) Subject to the provisions of paragraph 2.2 and Section 3, as of the Effective Date and for the Term, LIFESCAN hereby grants to UNIVERSAL BIOSENSORS a worldwide, royalty-free, exclusive license, with the right to sublicense, to make, have made, use, sell under and exploit in any way the LIFESCAN Acquired Patents and the LIFESCAN Acquired Know-How in the Licensed Fields.
 
      b.) In order to exercise UNIVERSAL BIOSENSORS’ rights to sublicense any or all of the rights licensed under paragraph 2.1a.), UNIVERSAL BIOSENSORS shall provide that each sublicense contains the terms and conditions set forth in Section 3 and paragraph 4.6 of this Agreement
 
  2.2   The license granted in paragraph 2.1a.) is subject to a reserved non-exclusive license in LIFESCAN and its Affiliates to make, have made, use, sell under and exploit in any way the LIFESCAN Acquired Patents and LIFESCAN Acquired Know-How in the Licensed Fields .

2

 

  2.3   In consideration of the license granted under paragraph 2.1a.), UNIVERSAL BIOSENSORS hereby grants to LIFESCAN a worldwide, royalty-free, irrevocable, non-exclusive license to make, have made, use, and sell under and exploit in any way in LIFESCAN’s Field any and all intellectual property resulting from UNIVERSAL BIOSENSORS’ improvements, modifications, or adaptations whether or not patentable (collectively, “Improvements”) in respect of the LIFESCAN Acquired Patents, LIFESCAN Acquired Know-How, or both.
 
      a.) All right, title and interest in and to the Improvements shall be in UNIVERSAL BIOSENSORS and UNIVERSAL BIOSENSORS at its sole discretion may, if registerable, register any of the Improvements in such territories (if any) that UNIVERSAL chooses.
 
      b.) UNIVERSAL BIOSENSORS shall, at LIFESCAN’s expense, grant registerable user or license agreements in respect of any registered intellectual property in any Improvements that LIFESCAN determines is required in any particular territory to make the license in this paragraph 2.1 effective.
 
      c.) Registered user or license agreements under paragraph 2.2 b.) shall be consistent with this paragraph 2.2, but otherwise shall be in usual or common form.
3.   RECAPTURE RIGHTS.
  3.1   In order for UNIVERSAL BIOSENSORS to maintain the exclusive license granted in paragraph 2.1a.), UNIVERSAL BIOSENSORS shall use its best efforts to use and exploit the LIFESCAN Acquired Patents and LIFESCAN Acquired Know-How in the Licensed Fields; provided, however that UNIVERSAL BIOSENSORS retains the discretion to determine the means and manner of its exploitation of LIFESCAN Acquired Patents and LIFESCAN Acquired Know-How. For purposes of this Section 3, “exploit” or “exploitation” means:
  a.)   using in research and development activities:
 
  b.)   using in developing, making, selling, and distributing Products;
 
  c.)   granting sublicenses in any Field within the Licensed Fields; and.
 
  d.)   developing, in conjunction with a.), b.) or c.), new patent applications or other intellectual property that derives from or, is a development of, any of the LIFESCAN Acquired Patents and LIFESCAN Acquired Know-How in the Licensed Fields.

3

 

  3.2   During the Term, UNIVERSAL BIOSENSORS shall provide to LIFESCAN periodic, written, summary reports on UNIVERSAL BIOSENSORS’ exploitation plans and any Improvements to which paragraph 2.3 applies, which reports shall be provided at least one (1) time per calendar year. LIFESCAN shall keep confidential any exploitation plans disclosed to it in under this paragraph 3.2.
 
  3.3   In the event that LIFESCAN is approached by a third party that desires a license in a Field within the Licensed Fields in any or all of the LIFESCAN Acquired Patents or LIFESCAN Acquired Know-How, LIFESCAN shall refer the third party to UNIVERSAL BIOSENSORS by identifying the third party, identifying a contact for the third party, and providing UNIVERSAL BIOSENSORS copies of any correspondence received by LIFESCAN from the third party (collectively, a “Referral”). UNIVERSAL BIOSENSORS shall acknowledge in writing to LIFESCAN receipt of the Referral within thirty (30) days of such receipt.
 
  3.4   If UNIVERSAL BIOSENSORS receives a Referral pursuant to paragraph 3.3, UNIVERSAL BIOSENSORS shall enter into good faith negotiations for grant of a license to the third party unless UNIVERSAL BIOSENSORS:
  a.)   is engaged in exploitation of the LIFESCAN Acquired Patents or LIFESCAN Acquired Know-How, as applicable, in the Field that is the subject of the Referral; or
 
  b.)   provides to LIFESCAN evidence that reasonably demonstrates to LIFESCAN that UNIVERSAL BIOSENSORS has bona fide plans to commence exploitation of the LIFESCAN Acquired Patent or LIFESCAN Acquired Know-How, as applicable, in the Field within twelve (12) months of the date of UNIVERSAL BIOSENSORS’ acknowledgment of the Referral.
  3.5   If UNIVERSALBIOSENSORS fails to enter into negotiations under paragraph 3.4 within three (3) months of the date of UNIVERSAL BIOSENSORS’ acknowledgment of the Referral, LIFESCAN shall have the right to convert the license granted under paragraph 2.1a.) to a non-exclusive license with respect to the Field and LIFESCAN Acquired Patent or LIFESCAN Acquired Know-How that is the subject of the Referral;
4.   Patent Prosecution and Maintenance; Patent Marking.

4

 

  4.1   a.) LIFESCAN shall accept liaison and financial responsibility for prosecution by a patent attorney, in independent practice nominated by LIFESCAN and approved by UNIVERSAL BIOSENSORS, of the application or applications within the LIFESCAN Acquired Patents directed to inventions within the Licensed Fields to allowance or to the point of necessary appeal from a final rejection by an Examiner of the USPTO, and those jurisdictions listed on Exhibit B attached hereto and made apart hereof and any other jurisdiction mutually agreed upon by the parties.
  b.)   Except as may be later separately agreed upon by the parties in writing, LIFESCAN does not accept responsibility for:
 
      i.) filing or prosecution of any appeal from a final rejection by an Examiner of the USPTO, or any other jurisdiction, of any of the patent applications; or
 
      ii.) the conduct of any interference in which an application or patent arising from an application may become involved.
  4.2   LIFESCAN will furnish UNIVERSAL BIOSENSORS copies of all office actions and LIFESCAN’s proposed responses thereto at least thirty (30) days prior to the earliest date set by the USPTO or corresponding foreign office for submission of the response and UNIVERSAL BIOSENSORS shall have the right to review and comment on LIFESCAN’s proposed response to such action.
 
  4.3   In the event that LIFESCAN elects not to proceed with the prosecution of an application under subparagraph 4.1 a.), LIFESCAN shall notify UNIVERSAL BIOSENSORS of such decision and UNIVERSAL BIOSENSORS shall have the right at any time thereafter to assume and continue at its own expense the prosecution of the application. Upon receipt by UNIVERSAL BIOSENSORS of such notice from LIFESCAN, LIFESCAN:
  a.)   shall be relieved of all further financial and other responsibility in respect to the application;
 
  b.)   shall have no further rights thereto in all jurisdictions for which UNIVERSAL BIOSENSORS assumes financial responsibility for the prosecution;
 
  c.)   shall enter into such assignments or other reasonably necessary documents in respect thereto in all jurisdictions for which UNIVERSAL BIOSENSORS assumes financial responsibility so as to properly vest

5

 

      ownership and the right to prosecute the application in UNIVERSAL BIOSENSORS or its nominee; and
 
  d.)   shall provide to UNIVERSAL BIOSENSORS the file histories of the application in LIFESCAN’s possession.
  4.4   Upon issuance of any patents resulting from the applications prosecuted pursuant to paragraph 4.1, LIFESCAN will accept responsibility for payment of maintenance fees for all jurisdictions mutually agreed upon by the parties. However, LIFESCAN shall have the right to discontinue the payment of any or all maintenance fees in any or all countries. In the event LIFESCAN discontinues such maintenance payments, LIFESCAN shall notify UNIVERSAL BIOSENSORS of such decision and UNIVERSAL BIOSENSORS may, at its option, maintain the patent solely at its own expense. Upon receipt by UNIVERSAL BIOSENSORS of such notice from LIFESCAN, LIFESCAN:
  a.)   shall be relieved of all further financial and other responsibility in respect to the patent at issue;
 
  b.)   shall have no further rights thereto in all jurisdictions for which UNIVERSAL BIOSENSORS has assumed the maintenance payments.
 
  c.)   shall enter into such assignments or other reasonably necessary documents in respect thereto in all jurisdictions for which UNIVERSAL BIOSENSORS assumes financial responsibility so as to properly vest ownership and the right to maintain the patent in UNIVERSAL BIOSENSORS or its nominee; and
 
  d.)   shall provide to UNIVERSAL BIOSENSORS the file histories of the patent in LIFESCAN’s possession.
  4.5   a.) In the event that UNIVERSAL BIOSENSORS grants a sublicense in the LIFESCAN Acquired Patents and receives a lump sum payment, actual or minimum royalties payment, or both ( a “Payment”) from the sublicensee, UNIVERSAL BIOSENSORS agrees to pay fifty percent (50 %) of such Payment (when received from time to time) to LIFESCAN in reimbursement of LIFESCAN’s payment of the prosecution and maintenance fees under this Section 4, such payment to LIFESCAN

6

 

      to cease at the end of the term of the LIFESCAN Acquired Patents that are the subject of the Payment from the sublicensee.
  B.)   LIFESCAN acknowledges to UNIVERSAL BIOSENSORS that, apart from the rights to Payments under this paragraph 4.5, LIFESCAN is not entitled to receive any other amount by way of royalty or similar payment in respect of the license granted herein.
  4.6   UNIVERSAL BIOSENSORS agrees to place in a conspicuous location on Products sold to third parties a patent notice, in accordance with 35 U.S.C. §287, and any corresponding provision of the laws of a jurisdiction other than the United States in which a Product is being sold, identifying the relevant LIFESCAN Patents, if any.
5.   TERMINATION.
  5.1   This Agreement shall extend until the end of the Term unless terminated earlier in accordance with this Section 5.
 
  5.2   This Agreement may be terminated by LIFESCAN in the event that UNIVERSAL BIOSENSORS fails to exploit the LIFESCAN Acquired Patents and LIFESCAN Acquired Know-How. For purposes of this paragraph 5.2:
  a.)   exploit has the same meaning as in paragraph 3.1; and
 
  b.)   if LIFESCAN wishes to terminate the Agreement pursuant to this paragraph 5.2, LIFESCAN shall first provide UNIVERSAL BIOSENSORS with ninety (90) days written notice of its intent to so terminate and, if at the expiration of the ninety (90) days, UNIVERSAL BIOSENSORS has not provided evidence to LIFESCAN that UNIVERSAL BIOSENSORS is exploiting the LIFESCAN Acquired Patents and the LIFESCAN Acquired Know-How, this Agreement shall terminate on the 91st day.
  5.3   This Agreement may be terminated by LIFESCAN in the event that UNIVERSAL BIOSENSORS is liquidated or is wound up or is in persistent and material breach of its obligations under this Agreement. LIFESCAN shall first provide UNIVERSAL BIOSENSORS with ninety (90) days written notice of its intent to so terminate and, if at the expiration of the ninety (90) days, UNIVERSAL BIOSENSORS has not rectified the breach, this Agreement shall terminate on the 91st day.
6.   ENFORCEMENT OF PATENTS.

7

 

  6.2   In the event that UNIVERSAL BIOSENSORS shall bring to LIFESCAN’s attention in writing any unlicensed infringement, within one of the Licensed Fields, of a LIFESCAN Acquired Patent and LIFESCAN does not, within six (6) months of receipt of such writing:
  a.)   secure cessation of the infringement;
 
  b.)   enter suit against the infringer; or
 
  c.)   engage, along with UNIVERSAL BIOSENSORS, in bona fide negotiations for the acceptance by the infringer of a sublicense under the patents,
UNIVERSAL BIOSENSORS shall thereafter have the right to sue for the infringement at its own expense and to collect for its own use all damages, profits, and awards, of whatever nature.
  6.2   Nothing in this Agreement shall be construed as an obligation on LIFESCAN’s part to enforce or defend the LIFESCAN Acquired Patents.
7.   WARRANTIES
  7.1   Nothing in this Agreement shall be construed as a warranty or representation of the validity, enforceability, or scope of the LIFESCAN Acquired Patents.
 
  7.2   Nothing in this Agreement shall be construed as a warranty or representation that a Product made, used, or sold under the license granted herein is or will be free from infringement of the intellectual property of third parties. LIFESCAN shall not be responsible for any award of damages arising out of charges that UNIVERSAL BIOSENSORS, alone or in combination with other entities or persons, infringed or infringes any claim of any third party patent by making, having made, using, selling or otherwise distributing Products.
LIFESCAN MAKES NO WARRANTIES OF ANY NATURE WITH RESPECT TO THE LIFESCAN PATENTS AND LIFESCAN KNOW-HOW INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR PARTCIULAR PURPOSE, OR OTHERWISE.
8.   NOTICES
     All notices, reports, requests, or statements provided for in this Agreement shall be given in writing and may be served either by personal delivery or by depositing the same, postage prepaid, in the United States first class, certified, or registered mails (date of deposit will be considered date of delivery) addressed to the parties respectively at the following addresses:

8

 

  a.   In the case of UNIVERSAL BIOSENSORS:
Beth Hughes
Venable Attorneys at Law
8010 Towers Crescent Drive
Suite 300
Vienna, Virginia 22182
USA
With a copy to:
Mr. Denis Hanley
Fax: 61 2 4365 5872
b.   In the case of LIFESCAN:
LifeScan, Inc.
1000 Gibraltar Drive
Milpitas, California 95035
Attn: President
Fax: (408) 956-4701
With a copy to:
Chief Patent Counsel
Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933 U.S.A.
Fax: 732-524-5008
9.   ARBITRATION
     Any controversy or claim arising out of or relating to this Agreement or the validity, inducement, or breach thereof, shall be settled by arbitration before a single arbitrator in accordance with the Commercial Arbitration Rules of the American Arbitration Association (“AAA”) then pertaining (available at www.adr.org), except where those rules conflict with this provision, in which case this provision controls. Any court with jurisdiction shall enforce this clause and enter judgment on any award. The arbitrator shall be an attorney who has at least fifteen (15) years of experience with a law firm or corporate law department of over twenty-five (25) lawyers or who was a judge of a court of general jurisdiction. He shall be selected within ten days of commencement of the arbitration from the AAA’s National Roster of Arbitrators pursuant to agreement or through selection procedures administered by the AAA. The arbitration shall be held in San Francisco, California and in rendering the award the arbitrator must apply

9

 

the substantive law of New York (except where that law conflicts with this clause), except that the interpretation and enforcement of this arbitration provision shall be governed by the Federal Arbitration Act. Within forty-five (45) days of initiation of arbitration, the parties shall reach agreement upon and thereafter follow procedures assuring that the arbitration will be concluded and the award rendered within no more than eight months from selection of the arbitrator. Failing such agreement, the AAA will design and the parties will follow procedures that meet such a time schedule. Each party has the right before or, if the arbitrator cannot hear the matter within an acceptable period, during the arbitration to seek and obtain from the appropriate court provisional remedies such as attachment, preliminary injunction, replevin, etc., to avoid irreparable harm, maintain the status quo or preserve the subject matter of the arbitration. THE ARBITRATOR SHALL NOT AWARD ANY PARTY PUNITIVE, EXEMPLARY, MULTIPLIED OR CONSEQUENTIAL DAMAGES, AND EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT TO SEEK SUCH DAMAGES. NO PARTY MAY SEEK OR OBTAIN PREJUDGMENT INTEREST OR ATTORNEYS’ FEES OR COSTS.
10.   GENERAL PROVISIONS.
  10.1   This Agreement, or any of its rights and obligations, shall not be assigned or transferred in whole or in part by either party without the prior written consent of the other party.
  a.)   Any attempted assignment or transfer of such rights or obligations without consent shall be void.
 
  b.)   A party shall not unreasonably withhold its consent to an assignment or transfer as part of the sale of the whole or part of the business of the assignor or transferor and the assignee or transferee is of reasonable financial standing.
  10.2   This Agreement shall be binding and inure to the benefit of the respective parties and their successors and assigns.
 
  10.3   The waiver of either party, whether express or implied, of any provision of this Agreement, or of any breach or default of either party, shall not be construed to be a continuing waiver of such provision, or any succeeding breach or default or of a waiver of any other provision of this Agreement.
 
  10.4   The interpretation, validity, and performance of this Agreement shall be governed by the laws of the State of New York, except for such laws directing application of the laws of another jurisdiction.
 
  10.5   Each party shall comply with all applicable United States and foreign governmental laws and regulations including, without limitation, any such laws directed to importation and exportation.

10

 

AGREED AND ACCEPTED TO:
                 
UNIVERSAL BIOSENSORS INC.       LIFESCAN, INC.
 
                
By:
  /s/ Denis Hanley       By:   /s/ Eric P. Milledge
 
               
Name:
  Denis Hanley       Name:   Eric P. Milledge
Title:
  Director       Title:   Company Group Chairman
 
               
 
                
Date:
  April 9, 2002       Date:   April 4, 2002
 
               

11

 

EXHIBIT A
LIFESCAN Patents

12

 

EXHIBIT A
Sensor Patents Granted
                                 
USF Reference   Title   Owner   Country   Patent Number   Issue Date   Issue Date
AU-C089
   Analytic Cell   FSG   AU   719581   11-Sep-1997   11-Sep-1997
AU-C089
   Analytic Cell   FSG   US   6193865   27-Feb-2001   15-Mar-1999
AU-C056
   Electrochemical Cell   FSG   AU   712939   19-Jun-1996   19-Jun-1996
AU-C056
   Electrochemical Cell   FSG   SG   53339   17-Aug-1999   19-Jun-1996
AU-C056
   Electrochemical Cell   FSG   US   6284125   04-Sep-2001   17-Apr-1998
AU-C064
   Electrochemical Cell   FSG   AU   705313   15-Nov-1996   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   US   6179979   30-Jan-2001   15-Mar-1999
AU-C141
   Electrochemical Cell   FSG   AU   741403   02-Aug-1999   02-Aug-1999
AU-C142
   Electrochemical Cell   FSG   AU   735132   02-Aug-1999   02-Aug-1999
AU-C137
   Electrochemical Cell (Notch)   FSG   AU   738128   15-Nov-1996   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   US   6174420   16-Jan-2001   18-May-1999
AU-C065
   Electrochemical Method   FSG   AU   705165   15-Nov-1996   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   IL   124494   03-Dec-2000   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   RU   2174679   10-Oct-2001   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   SG   53703   19-Sep-2000   15-Nov-1996
AU-C080
   Electrochemical Method   FSG   US   5942102   24-Aug-1999   05-Jul-1997
AU-C094
   Improved Electrochemical Cell   FSG   AU   723768   25-Mar-1998   25-Mar-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   US   6325917   04-Dec-2001   11-Feb-2000
AU-C167
   Method and device for sampling and analyzing interstitial fluid and whole blood samples   FSG   WO   WO 01/72220   04-Oct-2001   26-Mar-2001
AU-C054
   Method of Defining an Electrode Area   FSG   AU   693678   11-Apr-1996   11-Apr-1996
AU-C054
   Method of Defining an Electrode Area   FSG   SG   45676   27-Apr-1999   11-Apr-1996
AU-C054
   Method of Defining an Electrode Area   FSG   US   5980709   09-Sep-1999   10-Oct-1997
AU-C161
   Method of Preventing short sampling of a capillary or wicking fill device   FSG   WO   WO 01/723395   04-Oct-2001   26-Mar-2001
AU-C041
   Novel Electrochemical Cells   FSG   AU   697214   12-Apr-1995   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   US   5863400   26-Jan-1999   24-Feb-1997
 
                                
 
   OWNER                            
 
   USF Filtration & Separations Group Inc   FSG                        

13

 

EXHIBIT A
Sensor Patents Pending
                         
USF Reference   Title   Owner   Country   Application Number   Filing Date
AU-C245
   Ambidextrous Strip   FSG   US            
AU-C089
   Analytic Cell   FSG   CA   2264288   11-Sep-1997
AU-C089
   Analytic Cell   FSG   EP   97938686.9   11-Sep-1997
AU-C089
   Analytic Cell   FSG   JP   513059/1998   11-Sep-1997
AU-C089
   Analytic Cell   FSG   WO   PCT/AU97/00599   11-Sep-1997
AU-C244
   Electrochemical Cell   FSG   US   09/709968   10-Nov-2000
AU-C056
   Electrochemical Cell   FSG   CA   2222525   19-Jun-1996
AU-C056
   Electrochemical Cell   FSG   CN   96194874.4   19-Jun-1996
AU-C056
   Electrochemical Cell   FSG   EP   96917287.3   19-Jun-1996
AU-C056
   Electrochemical Cell   FSG   JP   502421/1997   19-Jun-1996
AU-C056
   Electrochemical Cell   FSG   KR   10-1997709488   19-Jun-1996
AU-C056
   Electrochemical Cell   FSG   WO   AU96/00365   19-Jun-1996
AU-C064
   Electrochemical Cell   FSG   BR   PI9611514-9   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   CA   2236850   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   CN   96199077.5   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   EP   96937919.7   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   HK   99103129.0   20-Jul-1999
AU-C064
   Electrochemical Cell   FSG   IL   124495   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   JP   518444/1997   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   KR   703701/1998   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   MX   983881   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   RU   98111492   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   SG   9802884.8   15-Nov-1996
AU-C064
   Electrochemical Cell   FSG   WO   PCT/AU96/00724   15-Nov-1996
AU-C215
   Electrochemical Cell   FSG   US   09/618515   18-Jul-2000
AU-C260
   Electrochemical Cell   FSG   IL   133994        
AU-C279
   Electrochemical Cell   FSG   US   09/840624   23-Apr-2001
AU-C317
   Electrochemical Cell   FSG   US            
AU-C137
   Electrochemical Cell (Notch)   FSG   AT   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   BE   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   BR       16-Dec-1999
AU-C137
   Electrochemical Cell (Notch)   FSG   CA            
AU-C137
   Electrochemical Cell (Notch)   FSG   CH   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   CN   99123109.0        

14

 

EXHIBIT A
                         
USF Reference   Title   Owner   Country   Application Number   Filling Date
AU-C137
   Electrochemical Cell (Notch)   FSG   DE   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   DK   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   EP   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   ES   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   FR   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   GB   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   GR   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   HK   00107699.9   30-Nov-2000
AU-C137
   Electrochemical Cell (Notch)   FSG   IL   132089   27-Sep-1999
AU-C137
   Electrochemical Cell (Notch)   FSG   IT   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   JP            
AU-C137
   Electrochemical Cell (Notch)   FSG   KR   10-2001-7014495   14-Nov-2001
AU-C137
   Electrochemical Cell (Notch)   FSG   LI   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   MX   999175   07-Oct-1999
AU-C137
   Electrochemical Cell (Notch)   FSG   NL   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   RU   2000104734   24-Feb-2000
AU-C137
   Electrochemical Cell (Notch)   FSG   SE   99202305.1   15-Nov-1996
AU-C137
   Electrochemical Cell (Notch)   FSG   SG            
AU-C316
   Electrochemical cell connector   FSG   US            
AU-C065
   Electrochemical Method   FSG   BR   PI9611513-0   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   CA   2236848   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   CN   96199076.7   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   EP   96937918.9   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   HK   99101616.4   14-Apr-1999
AU-C065
   Electrochemical Method   FSG   JP   518443/1997   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   KR   703700/1998   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   MX   983882   15-Nov-1996
AU-C065
   Electrochemical Method   FSG   WO   PCT/AU96/00723   15-Nov-1996
AU-C213
   Electrochemical method for measuring chemical reaction rates   FSG   AR   P010103342   13-Jul-2001
AU-C213
   Electrochemical method for measuring chemical reaction rates   FSG   MY   PI20013295   11-Jul-2001
AU-C213
   Electrochemical method for measuring chemical reaction rates   FSG   TH   066874   12-Jul-2001
AU-C213
   Electrochemical method for measuring chemical reaction rates   FSG   TW   90117040   12-Jul-2001
AU-C213
   Electrochemical method for measuring chemical reaction rates   FSG   US   09/616556   14-Jul-2000
AU-C213
   Electrochemical method for measuring chemical reaction rates   FSG   WO   PCT/US01/21314   06-Jul-2001
AU-C131
   Heated Electrochemical Cell   FSG   AU   29124/99   11-Mar-1999

15

 

EXHIBIT A
                         
USF Reference   Title   Owner   Country   Application Number   Filling Date
AU-C131
   Heated Electrochemical Cell   FSG   CA   2322757   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   DE   99910001.9   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   EP   99910001.9   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   ES   99910001.9   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   FR   99910001.9   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   GB   99910001.9   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   HK   01103634.5   25-May-2001
AU-C131
   Heated Electrochemical Cell   FSG   IT   99910001.9   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   JP   2000-535917   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   NL   99910001.9   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   TW   88103765   11-Mar-1999
AU-C131
   Heated Electrochemical Cell   FSG   US   09/659470   11-Sep-2000
AU-C131
   Heated Electrochemical Cell   FSG   WO   PCT/AU99/00152   11-Mar-1999
AU-C094
   Improved Electrochemical Cell   FSG   CA   2284532   25-Mar-1998
AU-C094
   Improved Electrochemical Cell   FSG   DE            
AU-C094
   Improved Electrochemical Cell   FSG   EP   98910522.6   25-Mar-1998
AU-C094
   Improved Electrochemical Cell   FSG   ES   98910522.6   25-Mar-1998
AU-C094
   Improved Electrochemical Cell   FSG   FR   98910522.6   25-Mar-1998
AU-C094
   Improved Electrochemical Cell   FSG   GB   98910522.6   25-Mar-1998
AU-C094
   Improved Electrochemical Cell   FSG   IT   98910522.6   25-Mar-1998
AU-C094
   Improved Electrochemical Cell   FSG   JP   543209/1998   25-Mar-1998
AU-C094
   Improved Electrochemical Cell   FSG   NL   98910522.6   25-Mar-1998
AU-C094
   Improved Electrochemical Cell   FSG   US   09/404119   23-Sep-1999
AU-C094
   Improved Electrochemical Cell   FSG   WO   PCT/AU98/00200   25-Mar-1998
AU-C166
   Improved Electrochemical Cell   FSG   US   09/568076   10-May-2000
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   AU   87263/98   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   CA   2300406   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   DE   98938521.6   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   EP   98938521.6   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   ES   98938521.6   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   FR   98938521.6   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   GB   98938521.6   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   GR   98938521.6   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   IE   98938521.6   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   IT   98938521.6   13-Aug-1998

16

 

EXHIBIT A
                         
USF Reference   Title   Owner   Country   Application Number   Filing Date
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   JP   2000-510018   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   NL   98938521.6   13-Aug-1998
AU-C107
   Method and Apparatus for Automatic Analysis   FSG   WO   PCT/AU98/00642   13-Aug-1998
AU-C307
   Method and Apparatus for Automatic Analysis   FSG   US   09/970461   02-Oct-2001
AU-C167
   Method and device for sampling and analyzing interstitial fluid and whole blood samples   FSG   TW   90108732   12-Apr-2001
AU-C167
   Method and device for sampling and analyzing interstitial fluid and whole blood samples   FSG   US   09/536235   27-Mar-2000
AU-C167
   Method and device for sampling and analyzing interstitial fluid and whole blood samples   FSG   WO   US01/09673   26-Mar-2001
AU-C054
   Method of Defining an Electrode Area   FSG   CA   2216911   11-Apr-1996
AU-C054
   Method of Defining an Electrode Area   FSG   EP   96908916.8   11-Apr-1996
AU-C054
   Method of Defining an Electrode Area   FSG   JP   530573/1996   11-Apr-1996
AU-C054
   Method of Defining an Electrode Area   FSG   WO   PCT/AU96/00210   11-Apr-1996
AU-C161
   Method of preventing short sampling of a capillary or wicking fill device   FSG   TW   90108733   12-Apr-2001
AU-C161
   Method of preventing short sampling of a capillary or wicking fill device   FSG   US   09/536234   27-Mar-2000
AU-C161
   Method of preventing short sampling of a capillary or wicking fill device   FSG   WO   US01/09675   26-Mar-2001
AU-C287
   Novel Electrochemical Cells   FSG   US   60/328846   10-Oct-2001
AU-C041
   Novel Electrochemical Cells   FSG   AT   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   BE   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   CH   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   DE   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   DK   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   EP   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   ES   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   FR   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   GB   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   GR   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   IE   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   IT   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   JP   526564/1995   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   LU   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   MC   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   NL   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   PT   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   SE   95915068.1   12-Apr-1995
AU-C041
   Novel Electrochemical Cells   FSG   WO   PCT/AU95/00207   12-Apr-1995
AU-C248
   Novel mediation strategy for enzyme linked electrochemical assays   FSG   US            

17

 

EXHIBIT A
                         
USF Reference   Title   Owner   Country   Application Number   Filing Date
AU-C095
   Sensor Connection Means   FSG   AT   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   AU   66044/98   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   BE   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   BR   PI9807987-5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   CA   2284634   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   CH   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   CN   98804325.4   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   DE   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   DK   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   EP   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   ES   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   FR   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   GB   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   GR   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   HK   00103935.2   29-Jun-2000
AU-C095
   Sensor Connection Means   FSG   IL   131980   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   IT   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   JP   544532/1998   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   KR   7008615/1999   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   MX   998659   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   NL   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   RU   99122339   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   SE   98907775.5   20-Mar-1998
AU-C095
   Sensor Connection Means   FSG   SG   9904624-5   20-Mar-1998
AU-C318
   Sensor Connection Means   FSG   US   09/399512   20-Sep-1999
AU-C132
   Sensor Connection Means Life   FSG   WO   PCT/AU98/00184   20-Mar-1998
AU-C132
   Sensor Connection Means Life   FSG   US   to be advised   04-Jan-2002
AU-C132
   Sensor with Improved Shelf Life   FSG   AU   29136/99   16-Mar-1999
AU-C132
   Sensor with Improved Shelf Life   FSG   CA   2322454   16-Mar-1999
AU-C132
   Sensor with Improved Shelf Life   FSG   DE   99910013.4   16-Mar-1999
AU-C132
   Sensor with Improved Shelf Life   FSG   EP   99910013.4   16-Mar-1999
AU-C132
   Sensor with Improved Shelf Life   FSG   ES   99910013.4   16-Mar-1999
AU-C132
   Sensor with Improved Shelf Life   FSG   FR   99910013.4   16-Mar-1999
AU-C132
   Sensor with Improved Shelf Life   FSG   GB   99910013.4   16-Mar-1999
AU-C132
   Sensor with Improved Shelf Life   FSG   HK   01104929.7   31-Jul-2001
AU-C132
   Sensor with Improved Shelf Life   FSG   IT   99910013.4   16-Mar-1999
AU-C132
   Sensor with Improved Shelf Life   FSG   JP   2000-538226   16-Mar-1999

18

 

EXHIBIT A
                     
USF Refrence   Tittle   Owner   Country   Application Number   Filing Date
AU-C132
  Sensor with Improved Shelf Life   FSG   NL   99910013.4    16-Mar-1999
AU-C132
  Sensor with Improved Shelf Life   FSG   TW   88104370    19-Mar-1999
AU-C132
  Sensor with Improved Shelf Life   FSG   US   09/664688   19-Sep-2000
AU-C132
  Sensor with Improved Shelf Life   FSG   WO   PCT/AU99/00166   16-Mar-1999
AU-C322
  Direct Immunoassay Sensor   FSG   AU   Invention Disclosure   14-Jan-02
 
  OWNER                
 
  USF Filtration & Separations Group Inc   FSG            

19

 

EXHIBIT A
Non Sensor Patents Pending
                     
Case Number   Tittle   Owner   Country   Application Number   Filing Date
AU-C199
  Anti-oxidant sensor disclosure   FSG   US   09/615691   14-JUl-2000
AU-C199
  Anti-oxidant sensor disclosure   FSG   WO   US01/21961   12-Jul-2001
AU-C214
  Hemoglobin Sensor   FSG   US   09/616512   14-Jul-2000
AU-C214
  Hemoglobin Sensor   FSG   WO   US01/21964   12-Jul-2001
AU-C198
  Immunosensor   FSG   US   09/616433   14-Jul-2000
AU-C198
  Immunosensor   FSG   WO   US01/22202   13-Jul-2000

20

 

EXHIBIT B
Australia
Canada
EPO:
France
Germany
Italy
Netherlands
Spain
United Kingdom
Japan
United States

21